Visit the original URL
A few days ago, the “Regulations on the Implementation of the Drug Administration Law of the People’s Republic of China (Draft for Comments)” issued by the State Food and Drug Administration, the one-month public consultation has officially ended. The newly added Article 83 clearly stipulates that third-party platform providers shall not directly participate in online drug sales activities. A person in charge of the pharmaceutical e-commerce platform business said that the biggest significance of this new policy is that it further clarifies the boundaries between self-operated and third-party platforms, requiring current e-commerce platforms to either purely conduct self-operated drug sales business, or simply do a business. Third-party platform. “In other words, after the implementation of this policy, drug online sales platforms are not allowed to be both referees and athletes.” (21st Century Business Herald)
media coverage
36Kr NetEase News 36Kr
Related events
- The state plans to prohibit third-party platforms from directly participating in online drug sales 2022-06-22
- The State Food and Drug Administration is studying the supervision measures for online sales of prescription drugs2019-11-06
- Amazon is eyeing online drug retail chain pharmacy chain CVS immediately fell 5% 2017-10-07
This article is reprinted from: https://readhub.cn/topic/8h2XneWNOgp
This site is for inclusion only, and the copyright belongs to the original author.